Explore

Spring Mulberry Expands Chocolate Recall Over Salmonella Concerns

Spring Mulberry Expands Chocolate Recall Over Salmonella Concerns

Spring & Mulberry has expanded its recall to include all 12 of its chocolate product lines due to potential Salmonella contamination. The U.S. Food and Drug Administration (FDA) announced that the recall was prompted by an investigation identifying a batch of dates as the likely contamination source. Initially, eight products were recalled, but the expansion now includes all flavors, such as Blood Orange and Sea Salt. Despite the recall, no illnesses have been reported, and all products have tested negative for Salmonella. The affected products have been available online and through select retailers since August 2025.

Nationwide Chocolate Recall Expanded Due to Salmonella Concerns

Nationwide Chocolate Recall Expanded Due to Salmonella Concerns

Spring & Mulberry has expanded its recall of chocolate bars nationwide after identifying a potential salmonella contamination in a specific ingredient. The recall, initially limited, now includes a broader range of products following a root-cause analysis. The company, in collaboration with the FDA, traced the contamination to a lot of date ingredients used in production. Although no illnesses have been reported, the recall is a precautionary measure to ensure consumer safety. Affected products are sold online and through select retailers.

Spring Mulberry Expands Nationwide Chocolate Recall Due to Salmonella Concerns

Spring Mulberry Expands Nationwide Chocolate Recall Due to Salmonella Concerns

Spring & Mulberry has expanded its nationwide recall of chocolate bars after identifying a potential salmonella contamination. The recall, initially limited, now includes a broader range of products following a root-cause analysis. The investigation, conducted with manufacturing partners and the FDA, pinpointed a specific lot of date ingredient as the likely source of contamination. Despite the recall, all finished products have tested negative for salmonella, and no illnesses have been reported. The affected chocolate bars, available since August 2025, include various flavors such as Blood Orange, Coffee, and Mint Leaf. Consumers are advised not to consume the affected products and can obtain refunds by photographing the packaging and contacting the company.

FDA's Baby Formula Safety Claims Questioned by Health Advocates Over Contamination Concerns

FDA's Baby Formula Safety Claims Questioned by Health Advocates Over Contamination Concerns

The U.S. Food and Drug Administration (FDA) recently announced that a significant number of baby formula samples tested for toxic chemicals met high safety standards. However, public health advocates have raised concerns, arguing that the data contradicts these claims. The FDA's Operation Stork Speed tested 300 baby formula samples for substances like Pfas, phthalates, lead, pesticides, and mercury. Despite the FDA's assurance of safety, independent scientists and health advocates point out that many samples were contaminated with these dangerous substances. The FDA's report indicates that while most Pfas compounds were not found in the samples, a majority still contained some level of Pfas, phthalates, and lead, which are known to pose health risks to infants. The lack of transparency regarding specific product names and the presence of multiple contaminants in samples further complicates the issue.

White House to Replace FDA Chief Marty Makary

White House to Replace FDA Chief Marty Makary

The White House is preparing to replace Food and Drug Administration (FDA) Commissioner Marty Makary following months of internal turmoil and external criticism. Makary, who was appointed by President Trump, has faced scrutiny from various industry groups and former FDA commissioners. The agency has experienced significant staff departures and has been criticized for its handling of drug and vaccine approvals. The decision to replace Makary is reportedly under consideration by President Trump, although he has publicly distanced himself from the decision. The White House has not yet announced a successor, and the timing of Makary's departure remains uncertain.

FDA Issues Recall for Multiple Snack Brands Due to Salmonella Risk

FDA Issues Recall for Multiple Snack Brands Due to Salmonella Risk

The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of several snack mix products due to potential salmonella contamination. The recall affects products sold under brands such as Fisher, Southern Style Nuts, Squirrel Brand, and Target's Good & Gather. The contamination risk is linked to a seasoning ingredient containing dry milk powder from a previously recalled supplier. Although no illnesses have been reported, the recall is a precautionary measure to prevent potential health risks.

Target's Good Gather Snack Brand Recalled Due to Salmonella Risk

Several varieties of snack mixes from Target's Good & Gather brand, along with other brands such as Fisher, Squirrel Brand, and Southern Style Nuts, have been voluntarily recalled due to potential Salmonella contamination. The recall was announced by John B. Sanfilippo & Son, Inc. and published by the Food and Drug Administration. The contamination risk stems from a seasoning made by a third-party supplier containing dry milk powder that was previously recalled. Although the seasoning tested negative for Salmonella before use, the recall is being conducted out of an abundance of caution. No illnesses have been reported in connection with these snack mixes, but consumers are advised to discard or return the products for a refund or replacement.

Exclusive-Kennedy's health officials explored US ban of some widely used antidepressants, sources say

Exclusive-Kennedy's health officials explored US ban of some widely used antidepressants, sources say

By Yasmeen Abutaleb and Bo Erickson WASHINGTON, May 8 (Reuters) - U.S. health department officials last week explored whether they could ban certain drugs in a widely prescribed class of antidepressants as Health Secretary Robert F.

Snack Mixes Recalled Over Potential Salmonella Contamination

Snack Mixes Recalled Over Potential Salmonella Contamination

John B. Sanfilippo & Son, Inc. has announced a voluntary recall of several snack mix products due to potential salmonella contamination. The recall affects products sold under the Fisher, Squirrel Brand, Southern Style Nuts, and Good & Gather brands. The issue stems from a seasoning made with dry milk powder that was previously recalled. Although the seasoning batches tested negative for salmonella, the recall is a precautionary measure. Consumers are advised not to consume the affected products and to return them for a refund or replacement. No illnesses have been reported in connection with the recall.

FDA Approves Fruit-Flavored E-Cigarettes for Adults Following Industry Appeals

FDA Approves Fruit-Flavored E-Cigarettes for Adults Following Industry Appeals

The U.S. Food and Drug Administration (FDA) has granted its first authorization for fruit-flavored electronic cigarettes specifically intended for adult smokers. This decision marks a significant policy shift, coming after months of lobbying from the vaping industry to President Trump. The authorization allows these products to be marketed to adults, potentially expanding the options available to smokers seeking alternatives to traditional tobacco products. The move is seen as a response to the vaping industry's efforts to provide adult smokers with more appealing options, while still maintaining regulatory oversight to prevent underage usage.

Louisiana Seeks Supreme Court Intervention to Halt Mailing of Abortion Pills Nationwide

Louisiana Seeks Supreme Court Intervention to Halt Mailing of Abortion Pills Nationwide

Louisiana's state attorneys have petitioned the Supreme Court to uphold a recent appeals court decision that would prevent the mailing of mifepristone, a medication used for abortions, across the United States. This request follows a ruling by the conservative 5th Circuit Court of Appeals, which reinstated a regulation requiring women to obtain the pills in person from a doctor. The appeals court's decision was put into immediate effect, but Justice Samuel A. Alito Jr. issued an administrative stay, temporarily halting the enforcement of the ruling. The Supreme Court is now tasked with determining whether Louisiana has the standing to challenge federal drug regulations and whether the judiciary can overrule the Food and Drug Administration (FDA). The FDA had previously relaxed restrictions on mifepristone, allowing it to be mailed, but is currently reviewing its safety record.

Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors

Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors

Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors